title: Pulmonary hypertension and dexfenfluramine.
abstract: Appetite suppressants, including aminorex and fenfluramine, have been associated with pulmonary hypertension ever since the well-known outbreak of primary pulmonary hypertension in Europe after treatment with aminorex. The usage of a new anorectic agent, dexfenfluramine, has recently increased dramatically in developed countries. We report 2 new cases of lethal pulmonary hypertension associated with the use of dexfenfluramine.
authors.forename: P
authors.initials: P
authors.lastname: Cacoub
authors.forename: R
authors.initials: R
authors.lastname: Dorent
authors.forename: P
authors.initials: P
authors.lastname: Nataf
authors.forename: J P
authors.initials: JP
authors.lastname: Houppe
authors.forename: J C
authors.initials: JC
authors.lastname: Piette
authors.forename: P
authors.initials: P
authors.lastname: Godeau
authors.forename: I
authors.initials: I
authors.lastname: Gandjbakhch
mesh_terms: D005260:Female; D005277:Fenfluramine / Q000009:adverse effects*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced* / Q000503:physiopathology; D008875:Middle Aged
chemical_list: D005277:Fenfluramine